首页> 外文期刊>Therapeutic advances in respiratory disease. >Predictive value of Chartis measurement for lung function improvements in bronchoscopic lung volume reduction
【24h】

Predictive value of Chartis measurement for lung function improvements in bronchoscopic lung volume reduction

机译:支气管镜肺体积减少肺功能改善图表测量的预测值

获取原文

摘要

Background: Bronchoscopic lung volume reduction (BLVR) via valve implantation can be achieved by targeting severely hyperinflated and emphysematously destructed lung areas in patients with chronic obstructive lung disease. Lack of collateral ventilation (CV) is important for good outcomes with BLVR. CV can be measured using the catheter-based Chartis system. The aim of this study was to evaluate the correlation between total exhaled volume drained from the target lobe measured by Chartis and clinical outcomes after BLVR in CV-negative patients. Methods: From January 2016 to March 2019, 60 patients were included in this retrospective single-center analysis. Drained volume (TVol) measured by Chartis was recorded and compared with lung function and physical performance parameters. Outcome variables included the percentage change in lung function [forced expiratory volume in 1?s (FEV 1 ), residual volume (RV), and inspiratory vital capacity (IVC)]. Secondary outcomes were the degree of target lobe volume reduction (TLVR), change in 6-min walk distance (6MWD), and change in chronic obstructive pulmonary disease (COPD) assessment test (CAT) score. Results: Drained volume correlated significantly with post-BLVR change in FEV 1 ( r?=?0.663), IVC ( r?=?0.611), RV ( r?=??0.368), and TLVR ( r?=?0.635) (all p??0.05). In a priori-defined patient subgroups based on drained volume [400?ml ( n?=?8)]; mean changes in FEV 1 were 2.6%, 17.4%, and 51.3%; in RV were ?3.9%, ?10.6%, and ?23.8%; in IVC were ?4.0%, 10.6%, and 62.4%; and in TLVR were 525?ml (39%), 1375?ml (73%) and 1760?ml (100%), respectively. There were no significant correlations between absolute and percentage changes in 6MWD and the CAT score. Lung volume reduction was diagnosed in 32 (53%) cases. Conclusion: Drained volume measured by the Chartis system correlated with functional improvement in CV-negative patients undergoing BLVR. The reviews of this paper are available via the supplemental material section.
机译:背景:通过瓣膜注入的支气管镜肺体积减少(BLVR)通过靶向慢性阻塞性肺病患者的严重充气和顽固地破坏的肺区,可以实现。缺乏抵押品通风(CV)对于具有BLVR的良好成果非常重要。可以使用基于导管的Chartis系统测量CV。本研究的目的是评估通过CV-Digal患者在BLVR后的CAPTIS和临床结果中从靶叶中排出的总呼出量之间的相关性。方法:2016年1月至2019年3月,60名患者包括在此回顾性单中心分析中。记录并与肺功能和物理性能参数进行记录并与肺功能和物理性能参数进行记录的排水量(TVOL)。结果变量包括肺功能的百分比变化[1?S(FEV 1),残余体积(RV)和吸气致命能力(IVC)]的百分比变化[强制呼气量。二次结果是目标叶体积减少(TLVR)的程度,6分钟步行距离(6MWD)的变化,以及慢性阻塞性肺病(COPD)评估试验(CAT)评分的变化。结果:耗尽的体积与BLVR后的FEV 1(R?= 0.663),IVC(r?= 0.611),RV(R?= ?? 0.368),以及TLVR(R?= 0.635) (所有p?<?0.05)。在基于排水量的优先鉴定的患者子组中[400?ml(n?=?8)]; FEV 1的平均变化为2.6%,17.4%和51.3%;在RV?3.9%,?10.6%,和?23.8%; IVC是4.0%,10.6%和62.4%;在TLVR中分别为525毫升(39%),分别为1375毫升(73%)和1760毫升(100%)。绝对和6MWD和CAT分数之间的百分比变化无显着相关性。肺部体积减少诊断为32例(53%)病例。结论:CALLIS系统测量的排水量与BLVR接受的CV阴性患者功能性改进相关。本文的评论可通过“补充”材料段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号